Skip to Content

Edwards Lifesciences Corp - Stock Quote EW

Rating as of

Morningstar's Edwards Lifesciences Corp Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Revolutionary Innovations Set Some Companies Apart in Medtech

Julie Utterback, CFA Senior Equity Analyst

Analyst Note

| Julie Utterback, CFA |

Healthcare innovation represents a key area of exponential growth, and we think the scientific community's understanding of medical interventions has increased significantly over time and is likely to continue fast-paced development during the decades ahead. Within healthcare innovation, we view two key areas of explosive growth potential: innovative therapies and innovative devices and diagnostics, the latter of which is the focus of our new research. While the medical device and diagnostic industry's innovation engine appears mostly evolutionary to us, revolutionary innovations can represent the spark that both pioneers new markets and widens economic moats through the intangible asset source that is often present in medtech. Massive growth in scientific advancements and medical articles, along with major increases in medical patents, supports exponential growth opportunities in certain pockets of the medtech industry, in our opinion.

Read Full Analysis

Edwards Lifesciences Corp's Company Profile

Business Description

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. Its key products include surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.

One Edwards Way
Irvine, CA, 92614
T +1 949 250-2500
Sector Healthcare
Industry Medical Devices
Most Recent Earnings Mar 31, 2022
Fiscal Year End Dec 31, 2022
Stock Type Aggressive Growth
Employees 15,700